Page last updated: 2024-09-04

celastrol methyl ester and Diseases, Metabolic

celastrol methyl ester has been researched along with Diseases, Metabolic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bi, Y; Guo, J; Liu, YX; Pan, LR; Tan, Y; Yu, XJ; Zhao, Q; Zhong, J	1

Other Studies

1 other study(ies) available for celastrol methyl ester and Diseases, Metabolic

Article	Year
Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:6 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Inflammasomes; Inflammation; Lipopolysaccharides; Liver; Male; Metabolic Diseases; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Peritonitis; Uric Acid	2021

Article

Year

Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:6

Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Inflammasomes; Inflammation; Lipopolysaccharides; Liver; Male; Metabolic Diseases; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Peritonitis; Uric Acid

2021